New NMOSD Resource Pack puts Treatment Information at your Fingertips

Treatment options for NMOSD continue to grow. In addition to the already existing off-label therapies, the FDA has approved the medications SolirisUplizna, and Enspryng for use in treating NMOSD.

In order to keep you informed, we at SRNA have developed additional online resources that cover the latest advancements in NMOSD care and therapeutics.

Our brand-new SRNA NMOSD resource pack includes:

We hope these resources will help you learn more about all NMOSD therapies, improve your quality of life, and better advocate for your care. Please reach out to us if you have any questions!